| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
47,312 |
47,312 |
47,312 |
47,312 |
| Total Sell Value |
$657,637 |
$657,637 |
$657,637 |
$657,637 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
1 |
1 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Glenn Gregory M |
President, R&D |
• – – |
2021-03-15 |
4 |
D |
$217.46 |
$28,705 |
D/D |
(132) |
7,498 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-03-15 |
4 |
OE |
$5.95 |
$1,157,843 |
D/D |
10,531 |
7,630 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-03-15 |
4 |
AS |
$196.88 |
$1,134,400 |
D/D |
(5,712) |
2,811 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2021-03-15 |
4 |
S |
$210.00 |
$5,174,536 |
D/D |
(24,500) |
16,099 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2021-03-15 |
4 |
OE |
$3.99 |
$478,330 |
D/D |
24,500 |
40,599 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-03-09 |
4 |
AS |
$168.09 |
$31,937 |
D/D |
(190) |
287 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
D |
$174.84 |
$31,296 |
D/D |
(179) |
477 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
D |
$174.84 |
$2,448 |
D/D |
(14) |
656 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
OE |
$5.95 |
$50,148 |
D/D |
3,404 |
670 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
AS |
$150.31 |
$493,824 |
D/D |
(3,021) |
287 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-02-26 |
4 |
AS |
$219.55 |
$652,759 |
D/D |
(2,895) |
275 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-02-26 |
4 |
OE |
$5.95 |
$42,892 |
D/D |
2,895 |
3,170 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-02-18 |
4 |
AS |
$264.09 |
$656,134 |
D/D |
(2,434) |
2,811 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-02-16 |
4 |
D |
$262.70 |
$597,643 |
D/D |
(2,275) |
5,245 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-02-16 |
4 |
D |
$262.70 |
$28,897 |
D/D |
(110) |
7,520 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-02-16 |
4 |
OE |
$5.95 |
$138,577 |
D/D |
10,531 |
7,630 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-02-16 |
4 |
AS |
$272.42 |
$1,614,812 |
D/D |
(5,712) |
2,811 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-02-09 |
4 |
AS |
$324.50 |
$62,953 |
D/D |
(194) |
287 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
D |
$290.18 |
$52,813 |
D/D |
(182) |
481 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
D |
$290.18 |
$2,321 |
D/D |
(8) |
663 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
OE |
$5.95 |
$50,160 |
D/D |
3,406 |
671 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
AS |
$282.00 |
$877,766 |
D/D |
(3,022) |
287 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-02-01 |
4 |
AS |
$239.04 |
$3,627,789 |
D/D |
(15,022) |
275 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-02-01 |
4 |
OE |
$5.95 |
$272,724 |
D/D |
15,022 |
15,297 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4 |
D |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
|
- |
|
453 Records found
|
|
Page 11 of 19 |
|
|
